Saudi Oncology Society clinical management guidelines for renal cell carcinoma - Wikidata - awgldk - TriplyDB

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

http://www.wikidata.org/entity/Q34997362

about

Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvement Saudi Oncology Society clinical management guidelines development

P2860

Q26801279-D1AFFA3F-E00F-4623-81E0-2F47682929A0 Q35183683-C4B0714D-7E7F-4493-95C2-5EC7ECE80A55

P2860

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

http://www.wikidata.org/entity/Q34997362

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@ast

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@en

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@nl

type

label

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@ast

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@en

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@nl

prefLabel

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@ast

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@en

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@nl

P1433

Q34997362-FDC3B650-ECED-474B-8B4B-D73E4C61CEBD

P1476

Q34997362-6022F07A-662D-46A3-A547-32323110E2AA

P2093

Q34997362-0D67FA43-C239-4A85-B537-07C1DBC31BED

Q34997362-1B687E0C-0A8D-4221-8132-4A4D68BAB0CD

Q34997362-35C76F8E-0D9C-40CE-A6E5-90093314F9AD

Q34997362-4729D391-34A4-4FB5-964E-6EF6E0AF2958

Q34997362-97E2B989-EDD8-41C6-BEB3-57EE39855F9C

Q34997362-9FE077EA-0EAD-40A9-AC71-92DBC5D756FE

Q34997362-B2C9918D-AF68-40F3-A60F-7DFBCE9CD668

Q34997362-BF40255A-F7B9-4074-BC47-AFEFD68775A3

Q34997362-D1E5F1D2-687E-4834-9931-2D9FD7EF4956

Q34997362-EB12A9F9-9706-4CC8-9F35-88E5B6AA8D0C

P2860

Q34997362-04C14969-F1B9-4013-829D-EF005C565177

Q34997362-061C8B84-F7F9-404C-9F22-0458AA8786B6

Q34997362-0E87062A-7F86-41EB-A39C-A4280BD220DF

Q34997362-1E381EC2-6336-4CF8-97E7-B0DCD4EA5C30

Q34997362-4C20D574-DD98-4670-9083-D5F58384CF19

Q34997362-6FB927D3-1903-47B1-840F-B0E9B34C893A

Q34997362-767F5E48-ED29-4DCA-971F-50802E4B4527

Q34997362-81A1A97E-E112-4AE1-87C2-05F13E5F46A7

Q34997362-913E413C-3D9D-47E9-B045-0AB7312DF2D3

Q34997362-935123BA-16CF-43D1-A100-B7E450AFC241

P304

Q34997362-AD77C340-25AA-47A8-BDC0-F985FA5B987A

P31

Q34997362-5B1BDF97-FE3C-40B0-BA28-471BC71BB039

P356

Q34997362-1318FA14-51A2-443E-80D0-AEDFFCA6BB46

P478

Q34997362-25F4B245-9954-48DF-B71A-9BF6FED4E5C6

P50

Q34997362-77688882-2A36-4C32-9763-8865E5D6638F

Q34997362-90AA1E89-55CC-4DB6-AD68-23B468C20D9F

P577

Q34997362-6D2514C0-C556-4291-98CB-BB483BAA1D5E

P5875

Q34997362-0E67D2B8-73EC-404C-8376-6C33A0069EFD

P698

Q34997362-D1AE98EB-1910-4A39-8653-A5A338FD7674

P932

Q34997362-35CBC00C-B81A-451C-A57A-292B8A938972

P356

0974-7796.78548

P1433

P1476

Saudi Oncology Society clinical management guidelines for renal cell carcinoma

@en

P2093

Ali Aljubran

http://www.w3.org/2001/XMLSchema#string

Amjad Rehman

http://www.w3.org/2001/XMLSchema#string

Ashraf Abusamra

http://www.w3.org/2001/XMLSchema#string

Esam Murshid

http://www.w3.org/2001/XMLSchema#string

Hussein Soudy

http://www.w3.org/2001/XMLSchema#string

Ibraheem Al Oraifi

http://www.w3.org/2001/XMLSchema#string

Khaled Al Othman

http://www.w3.org/2001/XMLSchema#string

Mohammed Al Otaibi

http://www.w3.org/2001/XMLSchema#string

Mohammed El-Naghi

http://www.w3.org/2001/XMLSchema#string

Yasser Bahader

http://www.w3.org/2001/XMLSchema#string

P2860

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.

Significant responses to platinum-based chemotherapy in renal medullary carcinoma.

P304

S3-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0974-7796.78548

http://www.w3.org/2001/XMLSchema#string

P478

3 Suppl

http://www.w3.org/2001/XMLSchema#string

P50

Shouki Bazarbashi

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51219840

http://www.w3.org/2001/XMLSchema#string

P698

21673849

http://www.w3.org/2001/XMLSchema#string

P932

3099484

http://www.w3.org/2001/XMLSchema#string